What does the lowering of the risk score of the PromarkerD test over time indicate in a trial of CANagliflozin?
Have PromarkerD test, you are at risk, take CANagliflozin, end. If this is right why test samples from the start of a trial and then again samples after 3 years?
Results of the study confirm the CANagliflozin hypothesis, which was CANagliflozin would result in a lower PromarkerD risk score, why would Janssen care about the PromarkerD risk score? What does this mean for patients taking CANagliflozin?
What does the lowering of the risk score of the PromarkerD test...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.015(1.41%) |
Mkt cap ! $137.4M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.06 | $1.02 | $136.4K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 443 | 1 |
View Market Depth
| Last trade - 15.52pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
-0.015 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.05 | $1.06 | $1.03 | 34377 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| PIQ (ASX) Chart |